Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D de Raucourt

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Head & Neck|March 1, 1996
Nodal failures in patients with NO N+ oral squamous cell carcinoma without capsular ruptureJ M Brugère, V F Mosseri, G Mamelle, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|January 1, 1991
[The value of extemporaneous study of the surgical margins of cancers of the upper aero-digestive tract. Apropos of 129 cases of oral and oropharyngeal tumors]P Barrellier, P Dupin, B Grimaux, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 22, 2013
Initial staging for squamous cell carcinoma of the mouth, larynx and pharynx (except nasopharynx). Part 3: general assessment. 2012 SFORL recommendationsE de Monès, S Vergez, B Barry, et al.
Revue De Laryngologie - Otologie - Rhinologie|July 6, 2010
[Interest of peri-operative immunonutrition in head and neck cancers]H Abou Mayaleh, C Vayer, C Amsellem, et al.
British Journal of Cancer|February 24, 2001
Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)C Domenge, C Hill, J L Lefebvre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2009
Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinomaC M Nutting, C M L van Herpen, A B Miah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2010
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neckR Mesía, F Rivera, A Kawecki, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 1, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelinesE de Monès, C Bertolus, P Y Salaun, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2016
Long-term update of the 24954 EORTC phase III trial on larynx preservationB Henriques De Figueiredo, C Fortpied, J Menis, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 26, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part I: Locoregional extension assessment: 2012 SFORL guidelinesS Vergez, S Morinière, F Dubrulle, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Head & Neck|March 1, 1996
Nodal failures in patients with NO N+ oral squamous cell carcinoma without capsular ruptureJ M Brugère, V F Mosseri, G Mamelle, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|January 1, 1991
[The value of extemporaneous study of the surgical margins of cancers of the upper aero-digestive tract. Apropos of 129 cases of oral and oropharyngeal tumors]P Barrellier, P Dupin, B Grimaux, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 22, 2013
Initial staging for squamous cell carcinoma of the mouth, larynx and pharynx (except nasopharynx). Part 3: general assessment. 2012 SFORL recommendationsE de Monès, S Vergez, B Barry, et al.
Revue De Laryngologie - Otologie - Rhinologie|July 6, 2010
[Interest of peri-operative immunonutrition in head and neck cancers]H Abou Mayaleh, C Vayer, C Amsellem, et al.
British Journal of Cancer|February 24, 2001
Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)C Domenge, C Hill, J L Lefebvre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2009
Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinomaC M Nutting, C M L van Herpen, A B Miah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2010
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neckR Mesía, F Rivera, A Kawecki, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 1, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelinesE de Monès, C Bertolus, P Y Salaun, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2016
Long-term update of the 24954 EORTC phase III trial on larynx preservationB Henriques De Figueiredo, C Fortpied, J Menis, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 26, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part I: Locoregional extension assessment: 2012 SFORL guidelinesS Vergez, S Morinière, F Dubrulle, et al.
Pageof 4